Drug intelligence / Profile preview

technetium tc-99m dextran

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Subcutaneous, Intradermal
01

Overview

Technetium Tc-99m dextran is a diagnostic radiopharmaceutical agent used in nuclear medicine for various imaging applications, including lymphoscintigraphy, detection of protein-losing enteropathy (PLE), and assessment of vascular permeability. It consists of the metastable, gamma-emitting radionuclide technetium-99m (99mTc) complexed with dextran, a branched polysaccharide. The agent's biodistribution and retention within specific fluid compartments are primarily determined by the molecular weight of the dextran carrier; high-molecular-weight formulations (e.g., ~81,000 Da) tend to remain within the intravascular space, making them suitable for blood-pool imaging, while other formulations are evaluated for visualizing lymphatic flow and identifying sentinel lymph nodes in breast cancer patients. Its mechanism of action relies on passive distribution within fluid compartments rather than specific receptor binding, allowing for detection by gamma cameras while minimizing radiation exposure due to the short half-life of 99mTc.

Other names
99mTc-dextran99mTc-DXtechnetium Tc 99m dextran

Beyond the preview

Go deeper on technetium tc-99m dextran.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium tc-99m dextran.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call